| 1. | Truter, Sharada L: 1 article (01/2009) |
| 2. | Supino, Phyllis G: 1 article (01/2009) |
| 3. | Herrold, Edmund M: 1 article (01/2009) |
| 4. | Gupta, Anuj: 1 article (01/2009) |
| 5. | Dumlao, Themy F: 1 article (01/2009) |
| 6. | Catanzaro, Daniel F: 1 article (01/2009) |
| 7. | Carter, John: 1 article (01/2009) |
| 8. | Borer, Jeffrey S: 1 article (01/2009) |
| 9. | Zhao, Jing: 1 article (01/2008) |
| 10. | Wang, Xue-Qing: 1 article (01/2008) |
| 1. | Muscular Dystrophies (Muscular Dystrophy)
12/01/2001
- "Recombinant cryptic human fibronectinase cleaves actin and myosin: substrate specificity and possible role in muscular dystrophy."
Order ALL the reference details at left... |
| 2. | Infection
01/01/2008
- "CONCLUSION: The earthworm fibronectinase (EFNase) cleaves FN much faster than the other proteins in serum, showing a potential to inhibit HBV infection through its suppressing the level of HBeAg. "
Order ALL the reference details at left... |
| 3. | Fibrosis (Cirrhosis)
01/01/2009
- "CONCLUSIONS: Collagen is relatively deficient in AR fibrosis, due at least in part to upregulated MMPs and downregulated TIMPs; fibronectinase is unaltered. "
Order ALL the reference details at left... |
| 1. | Matrix Metalloproteinases
|
| 2. | Proteins (Proteins, Gene)
|
| 3. | Myosins (Myosin)
|
| 4. | Hepatitis B e Antigens
|
| 5. | Collagen
|
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
Analytic charts allow you and your physicians to see at a glance the
treatment options—including new, promising, off-label and experimental.
| Price: | $8.50 USD
& Delivery via
PDF download
updates for 1 year |
| Price: | $45.00 USD
access via web interface 1 year subscription |